Back to Search Start Over

Mutations inTPM3are a common cause of congenital fiber type disproportion

Authors :
Michael C Fahey
Norma B. Romero
Robert L. Smith
Annick Labarre-Vila
Rakesh Patel
Nigel F. Clarke
Danielle E. Dye
Edward S. Johnson
Nicole Monnier
Hannah Kolski
Remi Bellance
Kathryn N. North
Nigel G. Laing
Esther Lim
Institute for Neuromuscular Research
The University of Sydney
Division of Pediatric Neurology
University of Alberta
Centre for Medical Research
The University of Western Australia (UWA)
John Hunter Children's Hospital
University Discipline of Paediatrics and Child Health
Starship Children's Hospital
University of Auckland [Auckland]
Monash Neurology
Monash Medical Centre [Clayton, Australia]
Centre de Référence Maladies Rares Neurologiques et Neuromusculaires
CHU Fort de France
Physiopathologie et thérapie du muscle strié
Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR14-Institut National de la Santé et de la Recherche Médicale (INSERM)
Department of Laboratory Medicine and Pathology
Centre de Référence des Maladies Neuromusculaires
CHU Grenoble
Laboratoire de biochimie et génétique moléculaire
Roux-Buisson, Nathalie
Source :
Annals of Neurology, Annals of Neurology, Wiley, 2008, 63 (3), pp.329-37. ⟨10.1002/ana.21308⟩, Annals of Neurology, 2008, 63 (3), pp.329-37. ⟨10.1002/ana.21308⟩
Publication Year :
2008
Publisher :
Wiley, 2008.

Abstract

International audience; OBJECTIVE: Congenital fiber type disproportion (CFTD) is a rare form of congenital myopathy in which the principal histological abnormality is hypotrophy of type 1 (slow-twitch) fibers compared with type 2 (fast-twitch) fibers. To date, mutation of ACTA1 and SEPN1 has been associated with CFTD, but the genetic basis in most patients is unclear. The gene encoding alpha-tropomyosin(slow) (TPM3) is a rare cause of nemaline myopathy, previously reported in only five families. We investigated whether mutation of TPM3 is a cause of CFTD. METHODS AND RESULTS: We sequenced TPM3 in 23 unrelated probands with CFTD or CFTD-like presentations of unknown cause and identified novel heterozygous missense mutations in five CFTD families (p. Leu100Met, p.Arg168Cys, p.Arg168Gly, p.Lys169Glu, p.Arg245Gly). All affected family members that underwent biopsy had typical histological features of CFTD, with type 1 fibers, on average, at least 50% smaller than type 2 fibers. We also report a sixth family in which a recurrent TPM3 mutation (p.Arg168His) was associated with histological features of CFTD and nemaline myopathy in different family members. We describe the clinical features of 11 affected patients. Typically, there was proximal limb girdle weakness, prominent weakness of neck flexion and ankle dorsiflexion, mild facial weakness, and mild ptosis. The age of onset and severity varied, even within the same family. Many patients required nocturnal noninvasive ventilation despite remaining ambulant. INTERPRETATION: Mutation of TPM3 is the most common cause of CFTD reported to date.

Details

ISSN :
15318249 and 03645134
Volume :
63
Database :
OpenAIRE
Journal :
Annals of Neurology
Accession number :
edsair.doi.dedup.....eb44d0804d46007c9a4fb29f60597310
Full Text :
https://doi.org/10.1002/ana.21308